Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005549579> ?p ?o ?g. }
- W2005549579 endingPage "199" @default.
- W2005549579 startingPage "191" @default.
- W2005549579 abstract "NAD biosynthesis is emerging as a key regulator of immune cell functions. Accordingly, inhibitors of the NAD‐synthesizing enzyme nicotinamide phosphoribosyltransferase (NAMPT) have anti‐inflammatory effects, counteract hematological malignancies and are being tested in clinical trials. Still, their effect on different cell types still waits to be fully investigated. Here we show that the NAMPT inhibitor FK866 induces NAD depletion in various mouse organs but selectively causes dramatic atrophy of the spleen red pulp. Accordingly, in cultured mouse lymphocytes exposed to FK866, NAD contents drop to 50% of basal values within 2 days, a condition sufficient to prompt complete cell death. Cultures of human lymphocytes are more resistant to FK866 and sustain a 50% NAD reduction for 5 days before dying. Death of both cell types can be prevented by different NAD precursors, indicating critical NAD homeostasis in lymphocytes. Indeed, inhibition of the NAD‐consuming enzyme poly(ADP‐ribose) polimerase‐1 suffices to prevent FK866‐induced NAD depletion and death of both lymphocyte types. Poly(ADP‐ribose) polymerase‐1‐null lymphocytes also undergo lower NAD depletion and reduced cell death when exposed to the drug. At variance with other cell types, neither apoptosis nor autophagy are exclusively responsible for lymphocyte death by FK866, consistent with a general impairment of lymphocyte homeostasis following NAD depletion. Data demonstrate a unique sensitivity of resting lymphocytes to NAD‐depleting agents, providing new hints of relevance to lymphocyte biology and therapeutic interventions with NAMPT inhibitors." @default.
- W2005549579 created "2016-06-24" @default.
- W2005549579 creator A5020212269 @default.
- W2005549579 creator A5040302483 @default.
- W2005549579 creator A5041992655 @default.
- W2005549579 creator A5054790797 @default.
- W2005549579 creator A5075877326 @default.
- W2005549579 creator A5079832202 @default.
- W2005549579 creator A5081229064 @default.
- W2005549579 creator A5082342925 @default.
- W2005549579 date "2013-11-26" @default.
- W2005549579 modified "2023-10-18" @default.
- W2005549579 title "Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes" @default.
- W2005549579 cites W1630171124 @default.
- W2005549579 cites W1902399643 @default.
- W2005549579 cites W1967488625 @default.
- W2005549579 cites W1981106431 @default.
- W2005549579 cites W1992969032 @default.
- W2005549579 cites W1995766860 @default.
- W2005549579 cites W1999601075 @default.
- W2005549579 cites W2006170651 @default.
- W2005549579 cites W2012538520 @default.
- W2005549579 cites W2014150894 @default.
- W2005549579 cites W2019240387 @default.
- W2005549579 cites W2020304127 @default.
- W2005549579 cites W2057580360 @default.
- W2005549579 cites W2058696051 @default.
- W2005549579 cites W2059650806 @default.
- W2005549579 cites W2086274343 @default.
- W2005549579 cites W2086809581 @default.
- W2005549579 cites W2090156221 @default.
- W2005549579 cites W2092950801 @default.
- W2005549579 cites W2095566224 @default.
- W2005549579 cites W2097259163 @default.
- W2005549579 cites W2103542843 @default.
- W2005549579 cites W2125961267 @default.
- W2005549579 cites W2130500541 @default.
- W2005549579 cites W2131193900 @default.
- W2005549579 cites W2134939903 @default.
- W2005549579 cites W2146791037 @default.
- W2005549579 cites W2152732481 @default.
- W2005549579 cites W2159957319 @default.
- W2005549579 cites W2160973157 @default.
- W2005549579 doi "https://doi.org/10.1038/icb.2013.85" @default.
- W2005549579 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24275857" @default.
- W2005549579 hasPublicationYear "2013" @default.
- W2005549579 type Work @default.
- W2005549579 sameAs 2005549579 @default.
- W2005549579 citedByCount "20" @default.
- W2005549579 countsByYear W20055495792014 @default.
- W2005549579 countsByYear W20055495792015 @default.
- W2005549579 countsByYear W20055495792016 @default.
- W2005549579 countsByYear W20055495792017 @default.
- W2005549579 countsByYear W20055495792019 @default.
- W2005549579 countsByYear W20055495792020 @default.
- W2005549579 countsByYear W20055495792021 @default.
- W2005549579 countsByYear W20055495792022 @default.
- W2005549579 countsByYear W20055495792023 @default.
- W2005549579 crossrefType "journal-article" @default.
- W2005549579 hasAuthorship W2005549579A5020212269 @default.
- W2005549579 hasAuthorship W2005549579A5040302483 @default.
- W2005549579 hasAuthorship W2005549579A5041992655 @default.
- W2005549579 hasAuthorship W2005549579A5054790797 @default.
- W2005549579 hasAuthorship W2005549579A5075877326 @default.
- W2005549579 hasAuthorship W2005549579A5079832202 @default.
- W2005549579 hasAuthorship W2005549579A5081229064 @default.
- W2005549579 hasAuthorship W2005549579A5082342925 @default.
- W2005549579 hasConcept C181199279 @default.
- W2005549579 hasConcept C182979987 @default.
- W2005549579 hasConcept C190283241 @default.
- W2005549579 hasConcept C203014093 @default.
- W2005549579 hasConcept C203522944 @default.
- W2005549579 hasConcept C2776901170 @default.
- W2005549579 hasConcept C2777088662 @default.
- W2005549579 hasConcept C2777761686 @default.
- W2005549579 hasConcept C2779728014 @default.
- W2005549579 hasConcept C2780391879 @default.
- W2005549579 hasConcept C31573885 @default.
- W2005549579 hasConcept C502942594 @default.
- W2005549579 hasConcept C55493867 @default.
- W2005549579 hasConcept C75520062 @default.
- W2005549579 hasConcept C82381507 @default.
- W2005549579 hasConcept C86803240 @default.
- W2005549579 hasConcept C95444343 @default.
- W2005549579 hasConceptScore W2005549579C181199279 @default.
- W2005549579 hasConceptScore W2005549579C182979987 @default.
- W2005549579 hasConceptScore W2005549579C190283241 @default.
- W2005549579 hasConceptScore W2005549579C203014093 @default.
- W2005549579 hasConceptScore W2005549579C203522944 @default.
- W2005549579 hasConceptScore W2005549579C2776901170 @default.
- W2005549579 hasConceptScore W2005549579C2777088662 @default.
- W2005549579 hasConceptScore W2005549579C2777761686 @default.
- W2005549579 hasConceptScore W2005549579C2779728014 @default.
- W2005549579 hasConceptScore W2005549579C2780391879 @default.
- W2005549579 hasConceptScore W2005549579C31573885 @default.
- W2005549579 hasConceptScore W2005549579C502942594 @default.
- W2005549579 hasConceptScore W2005549579C55493867 @default.
- W2005549579 hasConceptScore W2005549579C75520062 @default.